Concerning to low molecular weight heparins (LMWHs) in acut coronary syndromes.
J
J
Borja
P
P
Olivella
D003327:Coronary Disease / Q000188:drug therapy*; D017985:Dalteparin / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male
D005343:Fibrinolytic Agents; D017985:Dalteparin